Research progress of the prognosis of chronic lymphocytic leukemia：reports from the 57th American Society of Hematology annual meeting
10.3760/cma.j.issn.1009-9921.2016.02.006
- VernacularTitle:慢性淋巴细胞白血病预后研究进展：第57届美国血液学会年会报道
- Author:
Fangtian WU
;
Wei XU
;
Jianyong LI
- Publication Type:Journal Article
- Keywords:
Leukemia,lymphocytic,chronic;
Prognosis;
American Society of Hematology annual meeting
- From:
Journal of Leukemia & Lymphoma
2016;25(2):83-85
- CountryChina
- Language:Chinese
-
Abstract:
Chronic lymphocytic leukemia (CLL) is a kind of malignant B-cell chronic lymphoproliferative disorder with highly heterogeneous clinical courses. Due to the recent advances in immunology, cellular genetics and molecular biology, several prognostic markers based on genetic, phenotypic, and molecular biology characteristics of CLL cells have emerged in the past decade. This article reviews the reports from the 57th American Society of Hematology (ASH) annual meeting on the progress of the prognosis of CLL.
